S&P 500
(-0.46%) 5 048.42 points
Dow Jones
(-0.98%) 38 086 points
Nasdaq
(-0.64%) 15 612 points
Oil
(0.23%) $83.76
Gas
(-4.58%) $1.563
Gold
(0.07%) $2 344.10
Silver
(0.15%) $27.40
Platinum
(0.84%) $928.20
USD/EUR
(0.09%) $0.933
USD/NOK
(0.15%) $10.97
USD/GBP
(0.09%) $0.800
USD/RUB
(0.02%) $92.18

Realtime updates for Apexigen, Inc. [APGN]

Exchange: NASDAQ Capital Market Sector: Healthcare Industry: Biotechnology
Last Updated22 Aug 2023 @ 15:59

8.48% $ 0.385

Live Chart Being Loaded With Signals

Commentary (22 Aug 2023 @ 15:59):

Apexigen Inc., a clinical-stage biopharmaceutical company, discovers and develops antibody therapeutics for oncology. It develops a pipeline of product candidates, including APX005M, a humanized agonist antibody that is in Phase II clinical development for the treatment of solid tumors, such as melanoma, esophageal and gastroesophageal junction, sarcoma, and rectal and ovarian cancers in combination with immunotherapy, chemotherapy, radiation therapy, and cancer vaccines; and APX601, a humanized antagonist antibody that is in Phase I/II clinical trial for the treatment of multiple tumor indications, as well as APX801, an NK cell engager to activate natural killer cells to killing of tumor cells...

Stats
Today's Volume 94 426.00
Average Volume 262 332
Market Cap 9.57M
EPS $0 ( 2023-11-21 )
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -0.225
ATR14 $0.0390 (10.13%)
Insider Trading
Date Person Action Amount type
2023-08-23 Zabrowksi Dan Sell 100 000 Stock Option (right to buy)
2023-08-23 Wertheimer Samuel P Sell 146 383 Common Stock
2023-08-23 Wertheimer Samuel P Sell 100 000 Stock Option (right to buy)
2023-08-23 Wertheimer Samuel P Sell 12 383 Warrants (right to buy)
2023-08-23 Wertheimer Samuel P Sell 1 845 Warrants (right to buy)
INSIDER POWER
-59.89
Last 97 transactions
Buy: 2 466 920 | Sell: 6 182 886

Volume Correlation

Long: 0.28 (neutral)
Short: 0.00 (neutral)
Signal:(44.278) Neutral

Apexigen, Inc. Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Apexigen, Inc. Correlation - Currency/Commodity

The country flag 0.43
( neutral )
The country flag 0.37
( neutral )
The country flag 0.00
( neutral )
The country flag 0.08
( neutral )
The country flag -0.50
( neutral )
The country flag -0.37
( neutral )

Apexigen, Inc. Financials

Annual 2022
Revenue: $0
Gross Profit: $0 (0.00 %)
EPS: $-1.590
Q2 2023
Revenue: $0
Gross Profit: $0 (0.00 %)
EPS: $-0.240
Q1 2023
Revenue: $0
Gross Profit: $0 (0.00 %)
EPS: $-0.240
Q4 2022
Revenue: $0
Gross Profit: $0 (0.00 %)
EPS: $-330.41

Financial Reports:

No articles found.

Apexigen, Inc.

Apexigen Inc., a clinical-stage biopharmaceutical company, discovers and develops antibody therapeutics for oncology. It develops a pipeline of product candidates, including APX005M, a humanized agonist antibody that is in Phase II clinical development for the treatment of solid tumors, such as melanoma, esophageal and gastroesophageal junction, sarcoma, and rectal and ovarian cancers in combination with immunotherapy, chemotherapy, radiation therapy, and cancer vaccines; and APX601, a humanized antagonist antibody that is in Phase I/II clinical trial for the treatment of multiple tumor indications, as well as APX801, an NK cell engager to activate natural killer cells to killing of tumor cells. The company was founded in 2010 and is based in San Carlos, California.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators